JPMorgan Chase & Co’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-159,857
Closed -$3.78M 6773
2023
Q4
$3.78M Sell
159,857
-202,830
-56% -$4.79M ﹤0.01% 2734
2023
Q3
$5.41M Sell
362,687
-60,774
-14% -$906K ﹤0.01% 2376
2023
Q2
$4.64M Sell
423,461
-118,946
-22% -$1.3M ﹤0.01% 2541
2023
Q1
$4.73M Buy
542,407
+539,415
+18,029% +$4.7M ﹤0.01% 2477
2022
Q4
$19K Sell
2,992
-3,331
-53% -$21.2K ﹤0.01% 4998
2022
Q3
$22K Buy
6,323
+2,980
+89% +$10.4K ﹤0.01% 4906
2022
Q2
$10K Sell
3,343
-1,300,368
-100% -$3.89M ﹤0.01% 5187
2022
Q1
$4.06M Sell
1,303,711
-78,835
-6% -$245K ﹤0.01% 2706
2021
Q4
$4.67M Buy
1,382,546
+51,271
+4% +$173K ﹤0.01% 2627
2021
Q3
$4.86M Buy
1,331,275
+1,301,429
+4,360% +$4.75M ﹤0.01% 2595
2021
Q2
$130K Sell
29,846
-60,621
-67% -$264K ﹤0.01% 4680
2021
Q1
$410K Buy
90,467
+7,903
+10% +$35.8K ﹤0.01% 4152
2020
Q4
$474K Buy
82,564
+56,742
+220% +$326K ﹤0.01% 3777
2020
Q3
$183K Buy
25,822
+2,515
+11% +$17.8K ﹤0.01% 3775
2020
Q2
$81K Sell
23,307
-763,101
-97% -$2.65M ﹤0.01% 4043
2020
Q1
$1.16M Buy
786,408
+763,825
+3,382% +$1.13M ﹤0.01% 2879
2019
Q4
$44K Sell
22,583
-460,816
-95% -$898K ﹤0.01% 4279
2019
Q3
$2.48M Buy
483,399
+464,479
+2,455% +$2.38M ﹤0.01% 2612
2019
Q2
$132K Sell
18,920
-277,583
-94% -$1.94M ﹤0.01% 3920
2019
Q1
$3.94M Sell
296,503
-19,223
-6% -$255K ﹤0.01% 2242
2018
Q4
$2.48M Buy
315,726
+302,078
+2,213% +$2.38M ﹤0.01% 2525
2018
Q3
$151K Sell
13,648
-34,453
-72% -$381K ﹤0.01% 3967
2018
Q2
$646K Buy
48,101
+10,316
+27% +$139K ﹤0.01% 3338
2018
Q1
$491K Buy
+37,785
New +$491K ﹤0.01% 3385
2016
Q3
Sell
-100
Closed 4296
2016
Q2
$0 Buy
+100
New ﹤0.01% 4385
2015
Q3
Sell
-25,000
Closed -$67K 3459
2015
Q2
$67K Buy
+25,000
New +$67K ﹤0.01% 3361